StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Long-lived assets — United Kingdom (U.K.) by Year

Long-lived assets — United Kingdom (U.K.) ($M) ($M)

Vertex Pharmaceuticals Long-lived assets — United Kingdom (U.K.): $168M in FY2025, down 5.1% from a year earlier.

Latest, FY2025
168
Period ended Dec 31, 2025
Change on a year earlier
-5.1%
177 in FY2024
History
16 years
Since FY2010
Sources
14
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-K Segment & Geographic Information Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLong-lived assets — United Kingdom (U.K.) ($M) ($M)Year on yearSource
FY2025Dec 31, 2025168-5.1%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 2024177+128.5%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 202377.3+2.1%Form 10-K (filed 2025-02-13) ↗
FY2022Dec 31, 202275.7+24.3%Form 10-K (filed 2024-02-15) ↗
FY2021Dec 31, 202160.9-1.0%Form 10-K (filed 2023-02-10) ↗
FY2020Dec 31, 202061.5+7.1%Form 10-K (filed 2022-02-09) ↗
FY2019Dec 31, 201957.4+88.2%Form 10-K (filed 2021-02-11) ↗
FY2018Dec 31, 201830.5-2.6%Form 10-K (filed 2020-02-13) ↗
FY2017Dec 31, 201731.3+16.4%Form 10-K (filed 2019-02-13) ↗
FY2016Dec 31, 201626.9-18.0%Form 10-K (filed 2018-02-15) ↗
FY2015Dec 31, 201532.8-2.4%Form 10-K (filed 2017-02-23) ↗
FY2014Dec 31, 201433.6+12.0%Form 10-K (filed 2015-02-13) ↗
FY2013Dec 31, 201330-2.0%Form 10-K (filed 2014-02-11) ↗
FY2012Dec 31, 201230.6+43.0%Form 10-K (filed 2013-03-01) ↗
FY2011Dec 31, 201121.4+39.9%Form 10-K (filed 2013-03-01) ↗
FY2010Dec 31, 201015.3–Form 10-K (filed 2012-02-22) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Long-lived assets — United Kingdom (U.K.) ($M), annual FY2010–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/geo-lla-gb

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.